Cubellis MV - Search Results

1

Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women.

Monticelli M, Hay Mele B, Benetti E, Fallerini C, Baldassarri M, Furini S, Frullanti E, Mari F, Andreotti G, Cubellis MV, Renieri A; Gen-Covid Multicenter Study. Monticelli M, et al. Among authors: cubellis mv. Genes (Basel). 2021 Apr 19;12(4):596. doi: 10.3390/genes12040596. Genes (Basel). 2021. PMID: 33921689 Free PMC article.

2

Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study.

Andreotti G, Guarracino MR, Cammisa M, Correra A, Cubellis MV. Andreotti G, et al. Among authors: cubellis mv. Orphanet J Rare Dis. 2010 Dec 7;5:36. doi: 10.1186/1750-1172-5-36. Orphanet J Rare Dis. 2010. PMID: 21138548 Free PMC article.

3

Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests.

Andreotti G, Citro V, De Crescenzo A, Orlando P, Cammisa M, Correra A, Cubellis MV. Andreotti G, et al. Among authors: cubellis mv. Orphanet J Rare Dis. 2011 Oct 17;6:66. doi: 10.1186/1750-1172-6-66. Orphanet J Rare Dis. 2011. PMID: 22004918 Free PMC article.

4

Identification and analysis of conserved pockets on protein surfaces.

Cammisa M, Correra A, Andreotti G, Cubellis MV. Cammisa M, et al. Among authors: cubellis mv. BMC Bioinformatics. 2013;14 Suppl 7(Suppl 7):S9. doi: 10.1186/1471-2105-14-S7-S9. Epub 2013 Apr 22. BMC Bioinformatics. 2013. PMID: 23815589 Free PMC article.

5

Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones.

Cammisa M, Correra A, Andreotti G, Cubellis MV. Cammisa M, et al. Among authors: cubellis mv. Orphanet J Rare Dis. 2013 Jul 24;8:111. doi: 10.1186/1750-1172-8-111. Orphanet J Rare Dis. 2013. PMID: 23883437 Free PMC article.

6

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

Andreotti G, Citro V, Correra A, Cubellis MV. Andreotti G, et al. Among authors: cubellis mv. Biochim Biophys Acta. 2014 Mar;1840(3):1214-24. doi: 10.1016/j.bbagen.2013.12.018. Epub 2013 Dec 21. Biochim Biophys Acta. 2014. PMID: 24361605 Free PMC article.

7

Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation.

Andreotti G, Pedone E, Giordano A, Cubellis MV. Andreotti G, et al. Among authors: cubellis mv. Mol Genet Genomic Med. 2013 May;1(1):32-44. doi: 10.1002/mgg3.3. Epub 2013 Mar 27. Mol Genet Genomic Med. 2013. PMID: 24498599 Free PMC article.

8

Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder.

Andreotti G, Cabeza de Vaca I, Poziello A, Monti MC, Guallar V, Cubellis MV. Andreotti G, et al. Among authors: cubellis mv. J Biol Chem. 2014 Dec 12;289(50):34900-10. doi: 10.1074/jbc.M114.586362. Epub 2014 Oct 16. J Biol Chem. 2014. PMID: 25324542 Free PMC article.

9

Taming molecular flexibility to tackle rare diseases.

Cubellis MV, Baaden M, Andreotti G. Cubellis MV, et al. Biochimie. 2015 Jun;113:54-8. doi: 10.1016/j.biochi.2015.03.018. Epub 2015 Apr 2. Biochimie. 2015. PMID: 25841341 Free PMC article.

10

Looking for protein stabilizing drugs with thermal shift assay.

Andreotti G, Monticelli M, Cubellis MV. Andreotti G, et al. Among authors: cubellis mv. Drug Test Anal. 2015 Sep;7(9):831-4. doi: 10.1002/dta.1798. Epub 2015 Apr 5. Drug Test Anal. 2015. PMID: 25845367 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters